Search
for
Sort by
Research 181–210 of 1000+
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Polycystic ovary syndrome (PCOS)
- Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Cutaneous Lupus Erythematosus
- Effect of Fibroblast Growth Factor 10 and an Interacting Non-Coding RNA on Secondary Hair Follicle Dermal Papilla Cells in Cashmere Goats’ Follicle Development Assessed by Whole-Transcriptome Sequencing Technology
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The Modulation of Aromatase and Estrogen Receptor Alpha in Cultured Human Dermal Papilla Cells by Dexamethasone: A Novel Mechanism for Selective Action of Estrogen via Estrogen Receptor Beta?
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- Current Treatments for Alopecia Areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Caspase-3 Regulates YAP-Dependent Cell Proliferation and Organ Size
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Deuruxolitinib for Alopecia Areata.
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Alopecia areata: current concepts
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Review of Promising Off-Label Use of Deucravacitinib
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Glabellar clinical and trichoscopic findings in patients with frontal fibrosing alopecia
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report